XELJANZ 10 mg/1 (Tofacitinib TABLET, FILM COATED) 10 mg/1

XELJANZ 10 mg tablets are a medication used to manage certain inflammatory conditions. This oral treatment is designed to help reduce symptoms and improve quality of life for eligible patients.

Strength

10 mg/1

Pack Size

60 TABLET, FILM COATED in 1 BOTTLE (0069-1002-01)

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

XELJANZ 10 mg tablets are commonly used to treat inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. This medication works by modulating the immune system to reduce inflammation and alleviate symptoms. Patients often wonder, 'What is XELJANZ used for?' and the answer includes managing joint pain, skin inflammation, and intestinal inflammation.

Side Effects

Common effects of XELJANZ 10 mg tablets may include headache, diarrhea, and upper respiratory tract infections. Some users also report nausea and increased cholesterol levels. These effects can vary from person to person, and it's important to discuss any concerns with a healthcare provider.

Precautions & Warnings

XELJANZ 10 mg tablets should be handled with care, especially for individuals with a history of infections or blood clots. Regular monitoring is advised to manage potential risks. Always follow the guidance of a healthcare professional when using this medication.

Avoid Interactions

XELJANZ 10 mg tablets may interact with other medications, including those that suppress the immune system or affect liver enzymes. Alcohol and certain supplements can also influence its effectiveness. It's crucial to inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

XELJANZ is used to manage inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.

XELJANZ 10 mg tablets are taken orally, typically as directed by a healthcare provider.

Common side effects may include headache, diarrhea, and upper respiratory tract infections.

XELJANZ may interact with other medications, so it's important to consult a healthcare provider before combining treatments.

XELJANZ may not be suitable for everyone, especially those with a history of infections or blood clots.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.